TriSalus Life Sciences, Inc. (TLSI)
4.43
-0.03
(-0.67%)
USD |
NASDAQ |
May 08, 16:00
4.44
+0.01
(+0.23%)
After-Hours: 20:00
TriSalus Life Sciences EPS Diluted (Quarterly) : -0.2082 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -1.03 |
| Perspective Therapeutics, Inc. | -0.5043 |
| AVITA Medical, Inc. | -0.3825 |
| Twist Bioscience Corp. | -0.7134 |
| Elutia, Inc. | -0.1283 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.753M |
| Revenue (Quarterly) | 13.20M |
| Total Expenses (Quarterly) | 22.96M |
| Enterprise Value | 285.59M |
| Gross Profit Margin (Quarterly) | 86.66% |
| Profit Margin (Quarterly) | -73.86% |
| Earnings Yield | -41.29% |
| Normalized Earnings Yield | -38.67 |